Stockreport

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF Commercial product shipments to be initiated in October to consumers with broad product availability by mid-Q4 2025 VIZZ is the first and only aceclidine-based eye dr [Read more]